FDA Inspection 1018711 — Helena Laboratories, Corp.

Helena Laboratories, Corp. — FEI 1618982

The FDA completed an inspection of Helena Laboratories, Corp. on Jul 21, 2017 in Beaumont, TX. The inspection was classified OAI (Official Action Indicated — regulatory and/or administrative actions are recommended). 8 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Official Action Indicated (OAI)
End Date
Jul 21, 2017
Fiscal Year
2017
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Beaumont, TX (United States)

Citations

IDCFRDescription
311821 CFR 820.75(a)Documentation
311921 CFR 820.75(b)Lack/Inad procedure-Monitoring/Control of Validated Proces
322621 CFR 820.70(g)(1)Maintenance schedule, Lack of or inadequate schedule
323321 CFR 820.72(a)Calibration, Inspection, etc. Procedures Lack of or Inadequ
326221 CFR 820.250(a)Statistical techniques - Lack of or inadequate procedures
369621 CFR 820.100(b)Documentation
421221 CFR 806.20(b)(4)Justification for not reporting
53921 CFR 820.70(b)Production and Process Change Procedures, lack of or Inad.

Need the full FDA record for Helena Laboratories, Corp.? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.

Get a free API key

How the connector works

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.